1 2 3 4
News & Information
Provenge Survival Benefit Greater in Blacks

Dr Sartor postulated that blacks either have a more robust immune system or their tumors are more responsive to immunotherapy compared with whites.

MDxHealth, Inc. (MXDHF) Release: ConfirmMDx Improves Prostate Cancer Diagnosis In African American Men

Test improved the identification of African American men at risk for aggressive cancer missed by a prostate biopsy.

May Webcast: Prostate Cancer Clinical Trial Opportunities & Possible Benefits

Summaries of four phase 3 prostate cancer clinical trials to provide patients with an overview of the purpose, possible benefits and risks for each.

Use Internet Explorer, Firefox or Safari browsers, DO not use Google Chrome browser) 

Emotionally Distressed Prostate Cancer Patients May Ask for Overly Aggressive Therapy

Men with low-risk prostate cancer who are not emotionally well may ask doctors for a more aggressive treatment regimen when it may not be necessary, a study suggests...

Family History Does Not Exclude Active Surveillance as Treatment Option for Prostate Cancer

Evidence suggest that having a family history of prostate cancer should not automatically exclude men from active surveillance consideration, although questions remain.